Form 4: PLAYSTUDIOS General Counsel Reports Share Sale Under Pre-Arranged Trading Plan
Insider Transaction Report
Joel Agena, General Counsel of PLAYSTUDIOS, Inc., reported the sale of 11,489 shares of Class A Common Stock at a weighted average price of $1.23 per share, executed under a Rule 10b5-1 trading plan.
Summary
- Joel Agena, General Counsel of PLAYSTUDIOS, Inc. (MYPS), reported a transaction on July 8, 2025.
- A total of 11,489 shares of Class A Common Stock were sold at a weighted average price of $1.23 per share, with individual transaction prices ranging from $1.19 to $1.25.
- This sale was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted on March 12, 2025, and previously disclosed in the Issuer's Quarterly Report on Form 10-Q filed on May 9, 2025.
- Following the reported transaction, Joel Agena directly beneficially owns 23,812 shares of Class A Common Stock.
- Current derivative security holdings include 166,668 Restricted Stock Units (RSUs) from a March 11, 2024 grant, 125,000 RSUs from a March 7, 2025 grant, and 125,000 Performance Stock Units (PSUs).
- Additionally, holdings include 233,043 stock options across three grants with exercise prices ranging from $0.90 to $1.44, and 28,040 earnout shares contingent on specific stock price targets.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While an insider sale might typically be seen as negative, its execution under a pre-arranged 10b5-1 plan mitigates concerns about immediate negative sentiment. The significant remaining unvested equity holdings also align the insider's interests with the company's long-term performance.
Positives
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned transaction rather than a reaction to new negative information.
- Significant unvested equity holdings, including 291,668 Restricted Stock Units, 125,000 Performance Stock Units, 233,043 stock options, and 28,040 earnout shares, align management's interests with long-term company performance.
Negatives
- An insider sale, even if pre-planned, can sometimes be perceived negatively by the market, particularly when the stock price is at a relatively low level ($1.23 weighted average sale price).
Risks
- Vesting of Restricted Stock Units and Performance Stock Units is contingent on the Reporting Person's continued employment with the company through the applicable vesting dates.
- The actual number of shares issued upon vesting of Performance Stock Units is contingent upon the achievement of certain pre-established performance metrics for the fiscal year ending December 31, 2025.
- Earnout shares are contingent on the Class A Common Stock closing price exceeding $12.50 and $15.00 per share for any 20 trading days within a 30-trading day period, ending no later than the five-year anniversary of the business combination closing (June 21, 2026), which are significantly higher than the current stock price.
Future Outlook
The document details future vesting schedules for various equity awards, contingent on continued employment and, for Performance Stock Units, achievement of specific performance metrics for the fiscal year ending December 31, 2025. Earnout shares are contingent on the stock price reaching $12.50 and $15.00 by June 21, 2026.
Industry Context
NA
Stakeholder Impact
- Shareholders: The sale by a General Counsel, even if pre-planned, might be viewed with slight caution, but the continued significant equity holdings suggest ongoing alignment with shareholder interests. The low sale price reflects current market valuation.
- Employees: The detailed vesting schedules for RSUs and PSUs indicate ongoing compensation and retention mechanisms for key personnel.
Next Steps
- Vesting of 125,000 Restricted Stock Units from the March 11, 2024 grant on May 15, 2025.
- Vesting of 41,667 Restricted Stock Units from the March 7, 2025 grant on May 15, 2025.
- Determination of Performance Stock Unit vesting based on fiscal year 2025 performance metrics.
- Vesting of 41,667 Restricted Stock Units from the March 7, 2025 grant on January 15, 2026.
- Vesting of 83,334 Restricted Stock Units from the March 11, 2024 grant on May 15, 2026.
- Potential vesting of 28,040 earnout shares if stock price targets ($12.50 and $15.00) are met by June 21, 2026.
- Vesting of 41,667 Restricted Stock Units from the March 7, 2025 grant on January 15, 2027.
- Vesting of 83,334 Restricted Stock Units from the March 11, 2024 grant on May 15, 2027.
- Vesting of 41,666 Restricted Stock Units from the March 7, 2025 grant on January 15, 2028.
Key Dates
| Date | Description |
|---|---|
| 09/01/2018 | Date stock options with an exercise price of $0.90 became exercisable. |
| 05/01/2020 | Date stock options with an exercise price of $1.01 became exercisable. |
| 02/01/2021 | Date of the Agreement and Plan of Merger for the business combination. |
| 01/01/2023 | Date stock options with an exercise price of $1.44 became exercisable. |
| 03/11/2024 | Date 358,335 unvested Restricted Stock Units were granted. |
| 05/15/2024 | Vesting date for 66,667 Restricted Stock Units from the March 11, 2024 grant. |
| 03/07/2025 | Date 166,667 unvested Restricted Stock Units were granted. |
| 03/12/2025 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 05/09/2025 | Date Issuer's Quarterly Report on Form 10-Q was filed, disclosing the trading plan. |
| 05/15/2025 | Vesting date for 125,000 Restricted Stock Units from the March 11, 2024 grant and 41,667 Restricted Stock Units from the March 7, 2025 grant. |
| 07/08/2025 | Date of the reported transaction (sale of shares). |
| 07/10/2025 | Date the Form 4 was signed. |
| 09/01/2025 | Expiration date for stock options with an exercise price of $0.90. |
| 12/31/2025 | End of fiscal year for which Performance Stock Unit vesting metrics are determined. |
| 01/15/2026 | Vesting date for 41,667 Restricted Stock Units from the March 7, 2025 grant. |
| 05/15/2026 | Vesting date for 83,334 Restricted Stock Units from the March 11, 2024 grant. |
| 06/21/2026 | Expiration date for earnout shares. |
| 01/15/2027 | Vesting date for 41,667 Restricted Stock Units from the March 7, 2025 grant. |
| 05/01/2027 | Expiration date for stock options with an exercise price of $1.01. |
| 05/15/2027 | Vesting date for 83,334 Restricted Stock Units from the March 11, 2024 grant. |
| 01/15/2028 | Vesting date for 41,666 Restricted Stock Units from the March 7, 2025 grant. |
| 01/01/2029 | Expiration date for stock options with an exercise price of $1.44. |
Recommendation
holdKeywords
PLAYSTUDIOS, MYPS, SEC Form 4, Insider Trading, Stock Sale, Joel Agena, General Counsel, Rule 10b5-1, Restricted Stock Units, Performance Stock Units, Stock Options, Earnout Shares, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.